title: Complete remission of Waldenström macroglobulinemia with azacitidine and rituximab.
authors: University Hospital Salzburg of the Paracelsus Medical University, Salzburg, Austria. lu.weiss@salk.at
authors: Lukas
authors: L
authors: Weiss
authors: Thomas
authors: T
authors: Melchardt
authors: Daniel
authors: D
authors: Neureiter
authors: Ralf
authors: R
authors: Kemmerling
authors: Sharareh
authors: S
authors: Moshir
authors: Lisa
authors: L
authors: Pleyer
authors: Richard
authors: R
authors: Greil
authors: Alexander
authors: A
authors: Egle
mesh_terms: D000368:Aged; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001374:Azacitidine / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D006801:Humans; D008297:Male; D012074:Remission Induction; D000069283:Rituximab; D008258:Waldenstrom Macroglobulinemia / Q000188:drug therapy*
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab; D001374:Azacitidine